Skip to main content
Figure 8 | Molecular Cancer

Figure 8

From: Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

Figure 8

The effect of integrin αv inhibitor on RANKL expression and osteoclast differentiation. A-C: Western blot analysis. Equal amount of total cellular lysates (50 μg protein; A, lanes 1 and 2) and conditioned media (CM-20 μg protein; lanes 3 and 4) were immunoblotted with a RANKL antibody. CM was used to detect the secreted levels of RANKL. The blot in A was reprobed with a GAPDH antibody after stripping (B). GAPDH level was used as a control for loading. The loading control for the CM is shown by the use of Coomassie blue staining of a gel ran in parallel (C). D and E. The effect of CM on osteoclast differentiation in vitro is shown. TRAP-positive osteoclasts are stained in dark purple. Images were captured (X 200) with an inverted phase contrast microscope. The results shown are representative of three independent experiments.

Back to article page

Molecular Cancer

ISSN: 1476-4598